These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11725953)

  • 1. Basic and therapeutic relevance of endothelin-mediated regulation.
    Goto K
    Biol Pharm Bull; 2001 Nov; 24(11):1219-30. PubMed ID: 11725953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New expansion of endothelin research: perspectives for clinical application of endothelin-receptor antagonists].
    Goto K; Miyauchi T
    Nihon Yakurigaku Zasshi; 2003 Feb; 121(2):91-101. PubMed ID: 12616854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin as a regulator of cardiovascular function in health and disease.
    Haynes WG; Webb DJ
    J Hypertens; 1998 Aug; 16(8):1081-98. PubMed ID: 9794709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pharmacology and pathophysiological significance of endothelin.
    Goto K; Hama H; Kasuya Y
    Jpn J Pharmacol; 1996 Dec; 72(4):261-90. PubMed ID: 9015736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelin in cardiovascular disease.
    Agapitov AV; Haynes WG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin and endothelin antagonism: roles in cardiovascular health and disease.
    Tamirisa P; Frishman WH; Kumar A
    Am Heart J; 1995 Sep; 130(3 Pt 1):601-10. PubMed ID: 7661079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin receptor antagonists: another potential alternative for cardiovascular diseases.
    Tostes RC; Muscará MN
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):287-301. PubMed ID: 16101562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling.
    Kirchengast M; Münter K
    Proc Soc Exp Biol Med; 1999 Sep; 221(4):312-25. PubMed ID: 10460693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelins as regulators of vascular tone in man.
    Haynes WG
    Clin Sci (Lond); 1995 May; 88(5):509-17. PubMed ID: 7614809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin receptor antagonists.
    Motte S; McEntee K; Naeije R
    Pharmacol Ther; 2006 Jun; 110(3):386-414. PubMed ID: 16219361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin: role in hypertension.
    Schiffrin EL
    Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with endothelin antagonists.
    Webb DJ; Strachan FE
    Am J Hypertens; 1998 Apr; 11(4 Pt 3):71S-79S. PubMed ID: 9607370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endothelins and their receptors in heart failure.
    Giannessi D; Del Ry S; Vitale RL
    Pharmacol Res; 2001 Feb; 43(2):111-26. PubMed ID: 11243712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelins and anti-endothelins.
    Bhatt AD
    J Assoc Physicians India; 1997 Nov; 45(11):868-72. PubMed ID: 11229190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelins in cardiovascular biology and therapeutics.
    Dhaun N; Webb DJ
    Nat Rev Cardiol; 2019 Aug; 16(8):491-502. PubMed ID: 30867577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Role of Endothelin in Early Vascular Aging.
    Trindade M; Oigman W; Fritsch Neves M
    Curr Hypertens Rev; 2017; 13(1):33-40. PubMed ID: 28413991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelins. A potential target for pharmacological intervention in diseases of the elderly.
    Lévesque H; Moore N; Cailleux N; Richard V; Thuillez C; Courtois H
    Drugs Aging; 1994 Mar; 4(3):221-37. PubMed ID: 8199396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin receptor antagonists and their developing role in cardiovascular therapeutics.
    Dupuis J
    Can J Cardiol; 2000 Jul; 16(7):903-10. PubMed ID: 10934309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelins as cardiovascular peptides.
    Levin ER
    Am J Nephrol; 1996; 16(3):246-51. PubMed ID: 8739884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.